Valuation: CelLBxHealth plc

Market Cap 16.48M 22.02M 19.31M 17.83M 31.23M 2.11B 31.86M 214M 83.29M 1.03B 82.69M 80.88M 3.58B P/E 2025 *
-0.25x
P/E 2026 * -0.62x
Enterprise Value 9.18M 12.27M 10.76M 9.93M 17.4M 1.17B 17.74M 119M 46.39M 575M 46.06M 45.05M 2B EV / Sales 2025 *
0.89x
EV / Sales 2026 * 0.69x
Free-Float
94.31%
Yield 2025 *
-
Yield 2026 * -

Last Transcript: CelLBxHealth plc

1 day+1.86%
1 week-1.53%
Current month-3.15%
1 month-17.94%
3 months+64.11%
6 months+40.67%
Current year+34.27%
1 week 1.41
Extreme 1.4055
1.67
1 month 1.3
Extreme 1.3
1.9
Current year 0.85
Extreme 0.85
2.8
1 year 0.85
Extreme 0.85
8
3 years 0.85
Extreme 0.85
37.4
5 years 0.85
Extreme 0.85
163.75
10 years 0.85
Extreme 0.85
163.75
Manager TitleAgeSince
Director of Finance/CFO - 01/01/1999
Chief Tech/Sci/R&D Officer - 01/01/2025
Chief Tech/Sci/R&D Officer - 05/06/2023
Director TitleAgeSince
Chairman 67 22/05/2023
Director/Board Member 61 12/01/2026
Director/Board Member 61 12/01/2026
Date Insider Type Main position Quantity % Market Cap.
12-19Buy

Chairman

5,000,000 1.5497%
12-19Buy

Chief Executive Officer

5,000,000 1.5497%
12-19Buy

Chief Financial Officer

2,500,000 0.7749%
Change 5-day change 1-year change 3-year change Capi.($)
+1.86%-1.53%-76.37%-87.43% 22.02M
-0.70%-5.37%+0.28%-28.83% 15.79B
-1.77%-4.99%+29.21%+88.65% 1.62B
+1.47%-5.12%-44.03%-79.48% 1.18B
+0.36%-3.46%-29.63%+33.62% 1.09B
+0.29%-3.35%-29.97%-54.68% 614M
-2.23%-9.38%-41.11%-58.26% 537M
+1.03%+0.75%+27.64%-52.83% 453M
-0.32%+0.65%-56.11%-59.77% 377M
+1.59%-6.44%-27.23%-26.83% 323M
Average +0.16%-3.06%-24.73%-32.58% 2.2B
Weighted average by Cap. -0.54%-3.75%-4.19%-22.30%

Financials

2025 *2026 *
Net sales 10.35M 13.84M 12.14M 11.21M 19.63M 1.32B 20.02M 135M 52.34M 648M 51.96M 50.83M 2.25B 21.65M 28.93M 25.38M 23.43M 41.04M 2.77B 41.86M 282M 109M 1.36B 109M 106M 4.71B
Net income -16.35M -21.85M -19.16M -17.69M -30.99M -2.09B -31.61M -213M -82.64M -1.02B -82.05M -80.25M -3.55B -8.55M -11.43M -10.02M -9.25M -16.21M -1.09B -16.53M -111M -43.22M -535M -42.91M -41.97M -1.86B
Net Debt -7.3M -9.76M -8.56M -7.9M -13.84M -934M -14.11M -94.97M -36.9M -457M -36.64M -35.83M -1.59B -1.6M -2.14M -1.88M -1.73M -3.03M -205M -3.09M -20.81M -8.09M -100M -8.03M -7.85M -348M
Logo CelLBxHealth plc
Cellbxhealth PLC, formerly ANGLE plc, is a global precision circulating tumor cell (CTC) intelligence company specializing in innovative circulating tumor cell solutions for use in research, drug development and clinical oncology. The product portfolio comprises the Parsortix platform with associated consumables and assays. Its Parsortix platform harvests CTCs from blood and enables comprehensive downstream analysis - including whole-cell imaging, proteomic profiling and full genomic workflows - supporting research, drug development and clinical oncology. Its Parsortix PC1 system is the first FDA cleared medical device for the capture and harvest of intact CTCs from metastatic breast cancer (MBC) patient blood for subsequent, user-validated analysis.Its Parsortix PR1 System is a semi-automated platform for epitope-independent CTC isolation, used in research and clinical trials for multiple cancer types.
Employees
119
Date Price Change Volume
09/07/26 GBX 1.477 +1.86% 5,000
08/07/26 GBX 1.450 -1.69% 2,251,058
07/07/26 GBX 1.475 -7.81% 4,128,376
06/07/26 GBX 1.600 +6.67% 2,912,628
03/07/26 GBX 1.500 0.00% 716,727
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.0145GBP
Average target price
0.0400GBP
Spread / Average Target
+175.86%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CLBX Stock